Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Civilization Ventures

Investor type Venture Capital
Founders Shahram Seyedin-Noor


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 42
Average round size
The average size of a deal this fund participated in
Portfolio companies 30
Rounds per year 8.40
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Pharmaceutical

The company was established in North America in United States. The main department of described VC is located in the San Francisco.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.

The fund was created by Shahram Seyedin-Noor.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Civilization Ventures, startups are often financed by U.S. Venture Partners (USVP), Designer Fund, The Vertical Group. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), Sanofi-Genzyme BioVentures, Norwest Venture Partners. In the next rounds fund is usually obtained by IndieBio, Wellington Management, U.S. Venture Partners (USVP).

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Biopharma, Artificial Intelligence. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Ulab Systems, CATALOG.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Civilization Ventures:
Typical Co-investors
Civilization Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Civilization Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Burch Investment Group Nashville, Tennessee, United States
Cedar Grove Investments Seattle, United States, Washington
Changjiang Fund China, Hubei, Wuhan
De-Carceration Fund Pennsylvania, Radnor, United States
Garu Investments -
Gestalt Theory Venture Partners -
Global Accelerator Network Boulder, Colorado, United States
Hailiying Beijing, Beijing, China
K1 Speed California, Irvine, United States
Lawtech Sandbox England, London, United Kingdom
MasterCard New York, Purchase, United States
Meyer Equity New York, New York, United States
Pamplona Capital Management England, London, United Kingdom
Saturn Five Austin, Texas, United States
Seneca Ventures Seattle, United States, Washington
Shenzhen Chuangfu Chengzhang Venture Capital China, Guangdong, Shenzhen
Teton Capital Advisers Jackson, United States, Wyoming

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kernal Biologics

$25M07 Jul 2022 Cambridge, Massachusetts, United States


Health Care
Health Diagnostics
$125M30 Mar 2022 California, United States

Omada Health

Health Care
$192M23 Feb 2022 San Francisco, California, United States


Health Care
$28M21 Dec 2021 Boston, Massachusetts, United States


$8M23 Nov 2021 São Paulo, São Paulo, Brazil

Health Care
Health Diagnostics
$11M05 Oct 2021 Salt Lake City, Utah, United States


$1M06 Sep 2021 Oxford, Oxfordshire, United Kingdom


$5M14 Jul 2021 Cambridge, Massachusetts, United States

Glyphic Biotechnologies

Life Science
$6M08 Jul 2021 San Francisco, California, United States
AXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders

– AXONIS secured an additional $5m in funding.
– The round was led by Alexandria Venture Investments with participation by R3 Bio, BoxOne Ventures and Civilization Ventures and two leading spinal cord injury non-profit foundations, the Christopher & Dana Reeve Foundation and Spinal Research.
– The new investment will support AXONIS’ next development phase as it continues to advance its novel neuromodulating technology into the clinic.
– The Company’s pipeline includes neuron-reviving therapeutics that enable an intrinsic ability of central nervous system (CNS) neurons to resist degeneration, restore excitation/inhibition balance and regenerate.
– The Company’s targeted indications include spinal cord injury and epilepsy, as well as broader neurodegenerative conditions.

Precision Medicine Company adyn Raises $2.5M Seed Funding for Personalized Birth Control

– adyn, a precision medicine company, announced today that it has closed a $2.5m seed round of funding.
– The round was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, Ascend VC, and angel investors including Anne Wojcicki of 23andMe, Nish Bhat of Color Genomics, Qasar Younis of Applied Intuition, and Ashley Mayer of Glossier.
– adyn uses proprietary hormone and genomic analyses to transform this selection process into a science and remove the guesswork.
– Using adyn’s precision medicine approach, patients and doctors will be able to personalize birth control selection, minimizing side effects ranging from annoyances like acne to life threatening conditions including blood clots and depression.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Civilization Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: